ERBB2 and gastric cancer: Patient 1 received Trastuzumab 4 mg/m2 as loading dose followed by 2 mg/m2 q3w accompanied by Paclitaxel 80 mg/m2 weekly as immunehistochemical staining revealed a positive Her2neu expression within 60% of all tumor cells, which is considered as positive in gastric cancer [12].